Robert Barrow
Chief Executive Officer, Director at Definium Therapeutics, Inc. (DFTX) since January 2022
Robert Barrow has filed 44 insider reports with the SEC since January 2022, as chief Executive Officer and director at Definium Therapeutics, Inc. (DFTX). In the last 12 months Robert Barrow sold $3.98M of stock on the open market. In the latest filing, on September 30, 2026, Robert Barrow sold 31,550 shares of Definium Therapeutics, Inc. (DFTX) for $1.15M at an average of $36.57.
- Filings
- 44
- Companies
- 1
- Bought on market
- $6,215
- Sold on market
- $5.42M
Companies where Robert Barrow is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Directorsince January 2022 | 2,213,090 | $6,215 | $5.42M | $6.22 | $29.12+368% | Sep 30, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 25, 2026-$1.15MDFTXChief Executive Officer Barrow Robert sold $1,153,784 worth of shares (31,550 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 2,213,090 units (for withholding tax)Form 4Open-market sale10b5-1 plan
- Sep 14, 2026DFTXChief Executive Officer Barrow Robert was granted 750,000 shares, increasing direct ownership by 50% to 2,244,640 unitsForm 4Grant or award
- Sep 3, 2026-$722KDFTXChief Executive Officer Barrow Robert was granted 40,000 shares and sold $721,733 worth of shares (19,023 units at $37.94) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 1,494,640 units (tax withholding)Form 4Grant or awardOpen-market sale10b5-1 plan
- Aug 12, 2026DFTXChief Executive Officer Barrow Robert was granted 375,000 shares, increasing direct ownership by 34% to 1,473,246 unitsForm 4Grant or award
- Jun 25, 2026-$1.32MDFTXChief Executive Officer Barrow Robert sold $1,315,236 worth of shares (29,208 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,098,246 units to satisfy withholding obligationForm 4Open-market sale10b5-1 plan
- Jun 22, 2026DFTXChief Executive Officer Barrow Robert was granted 375,000 shares, increasing direct ownership by 50% to 1,127,454 unitsForm 4Grant or award
- Mar 25, 2026-$451KDFTXSEC Form 4 filed by Barrow RobertForm 4Open-market sale10b5-1 plan
- Feb 3, 2026DFTXChief Executive Officer Barrow Robert was granted 320,000 shares, increasing direct ownership by 41% to 1,098,477 unitsForm 4Grant or award
- Dec 26, 2025-$339KDFTXChief Executive Officer Barrow Robert sold $339,072 worth of shares (25,791 units at $13.15), decreasing direct ownership by 3% to 778,477 unitsForm 4Open-market sale10b5-1 plan
- Sep 25, 2025-$252KDFTXChief Executive Officer Barrow Robert sold $252,037 worth of shares (25,797 units at $9.77), decreasing direct ownership by 3% to 804,268 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2025-$180KDFTXChief Executive Officer Barrow Robert sold $180,139 worth of shares (26,491 units at $6.80), decreasing direct ownership by 3% to 830,065 unitsForm 4Open-market sale10b5-1 plan
- Mar 25, 2025-$143KDFTXChief Executive Officer Barrow Robert sold $142,942 worth of shares (21,208 units at $6.74), decreasing direct ownership by 2% to 856,556 unitsForm 4Open-market sale10b5-1 plan
- Mar 12, 2025DFTXChief Executive Officer Barrow Robert was granted 350,000 shares, increasing direct ownership by 66% to 877,764 unitsForm 4Grant or award
- Dec 26, 2024-$142KDFTXChief Executive Officer Barrow Robert sold $141,958 worth of shares (19,106 units at $7.43), decreasing direct ownership by 4% to 526,666 unitsForm 4Open-market sale10b5-1 plan
- Sep 25, 2024-$118KDFTXChief Executive Officer Barrow Robert sold $118,231 worth of shares (19,771 units at $5.98), decreasing direct ownership by 3% to 545,772 unitsForm 4Open-market sale10b5-1 plan
- Aug 20, 2024+$6,215DFTXChief Executive Officer Barrow Robert bought $6,215 worth of shares (1,000 units at $6.21), increasing direct ownership by 0.18% to 565,543 unitsForm 4Open-market purchase
- Jun 25, 2024-$113KDFTXChief Executive Officer Barrow Robert sold $113,058 worth of shares (15,659 units at $7.22), decreasing direct ownership by 3% to 564,543 unitsForm 4Open-market sale10b5-1 plan
- Mar 25, 2024-$157KDFTXBarrow Robert sold $156,930 worth of shares (16,519 units at $9.50), decreasing direct ownership by 3% to 580,202 unitsForm 4Open-market sale10b5-1 plan
- Feb 27, 2024DFTXSEC Form 4 filed by Barrow RobertForm 4Grant or award
- Dec 26, 2023-$48.1KDFTXBarrow Robert sold $48,050 worth of shares (13,237 units at $3.63), decreasing direct ownership by 2% to 596,721 unitsForm 4Open-market sale
- Sep 25, 2023-$48.3KDFTXBarrow Robert sold $48,274 worth of shares (13,499 units at $3.58), decreasing direct ownership by 2% to 611,729 unitsForm 4Open-market sale
- Jun 27, 2023-$49.6KDFTXSEC Form 4 filed by Barrow RobertForm 4Open-market sale
- Mar 14, 2023DFTXSEC Form 4: Barrow Robert was granted 400,000 shares, increasing direct ownership by 167% to 638,959 unitsForm 4Grant or award
- Mar 1, 2023-$29KDFTXSEC Form 4: Barrow Robert sold $29,038 worth of shares (8,273 units at $3.51), decreasing direct ownership by 3% to 238,959 units (withholding tax)Form 4Open-market sale
- Dec 21, 2022-$10.4KDFTXSEC Form 4: Barrow Robert sold $10,386 worth of shares (3,861 units at $2.69), decreasing direct ownership by 2% to 247,232 units to satisfy withholding obligationForm 4Open-market sale
- Oct 25, 2022-$3,392DFTXSEC Form 4: Barrow Robert sold $3,392 worth of shares (1,207 units at $2.81), decreasing direct ownership by 0.48% to 251,093 units to satisfy withholding obligationForm 4Open-market sale
- Oct 18, 2022-$3,794DFTXSEC Form 4: Barrow Robert sold $3,794 worth of shares (1,220 units at $3.11), decreasing direct ownership by 0.48% to 252,300 units to cover taxesForm 4Open-market sale
- Sep 26, 2022-$6,965DFTXSEC Form 4: Barrow Robert sold $6,965 worth of shares (1,264 units at $5.51), decreasing direct ownership by 0.50% to 253,520 units to satisfy withholding taxForm 4Open-market sale
- Sep 16, 2022-$9,801DFTXSEC Form 4: Barrow Robert sold $9,801 worth of shares (1,350 units at $7.26), decreasing direct ownership by 0.53% to 254,784 units to satisfy withholding obligationForm 4Open-market sale
- Aug 31, 2022-$14.3KDFTXSEC Form 4: Barrow Robert sold $14,331 worth of shares (1,228 units at $11.67), decreasing direct ownership by 0.48% to 256,134 units (tax liability)Form 4Open-market sale
- Aug 16, 2022-$13.8KDFTXSEC Form 4: Barrow Robert sold $13,838 worth of shares (20,350 units at $0.68), decreasing direct ownership by 0.52% to 3,860,438 units (for tax liability)Form 4Open-market sale
- Jul 25, 2022-$12.9KDFTXSEC Form 4: Barrow Robert sold $12,890 worth of shares (18,681 units at $0.69), decreasing direct ownership by 0.48% to 3,880,788 units (withholding obligation)Form 4Open-market sale
- Jul 18, 2022-$13.6KDFTXSEC Form 4: Barrow Robert sold $13,572 worth of shares (19,388 units at $0.70), decreasing direct ownership by 0.49% to 3,899,469 units to cover withholding taxForm 4Open-market sale
- Jun 27, 2022-$25.7KDFTXSEC Form 4: Barrow Robert sold $25,733 worth of shares (36,762 units at $0.70), decreasing direct ownership by 0.93% to 3,918,857 units (tax withholding)Form 4Open-market sale
- Jun 16, 2022-$14.9KDFTXSEC Form 4: Barrow Robert sold $14,892 worth of shares (21,275 units at $0.70), decreasing direct ownership by 0.53% to 3,955,619 units (withholding obligation)Form 4Open-market sale
- May 25, 2022-$14.2KDFTXSEC Form 4: Barrow Robert sold $14,180 worth of Subordinate Voting Shares (18,415 units at $0.77), decreasing direct ownership by 0.46% to 3,976,894 units (for tax liability)Form 4Open-market sale
- May 18, 2022-$13.5KDFTXSEC Form 4: Barrow Robert sold $13,453 worth of Subordinate Voting Shares (18,948 units at $0.71), decreasing direct ownership by 0.47% to 3,995,309 units (for withholding tax) (Amendment)Form 4Open-market sale
- May 15, 2022DFTXSEC Form 4: Barrow Robert covered exercise/tax liability with 18,948 units of Subordinate Voting Shares, decreasing direct ownership by 0.47% to 3,995,309 units (for tax liability)Form 4Shares withheld for taxes or exercise price
- Apr 18, 2022DFTXSEC Form 4: Barrow Robert covered exercise/tax liability with 19,110 units of Subordinate Voting Shares, decreasing direct ownership by 0.47% to 4,014,257 units to satisfy tax liabilityForm 4Shares withheld for taxes or exercise price
- Mar 24, 2022DFTXSEC Form 4: Barrow Robert was granted 1,820,000 units of Subordinate Voting Shares, increasing direct ownership by 82% to 4,033,367 unitsForm 4Grant or award
- Mar 15, 2022DFTXSEC Form 4: Barrow Robert covered exercise/tax liability with 12,612 units of Subordinate Voting Shares, decreasing direct ownership by 0.57% to 2,213,367 units to cover withholding taxForm 4Shares withheld for taxes or exercise price
- Feb 15, 2022DFTXSEC Form 4: Barrow Robert covered exercise/tax liability with 18,734 units of Subordinate Voting Shares, decreasing direct ownership by 0.83% to 2,225,979 units (for withholding tax)Form 4Shares withheld for taxes or exercise price
- Jan 15, 2022DFTXSEC Form 4: Barrow Robert covered exercise/tax liability with 190,287 units of Subordinate Voting Shares, decreasing direct ownership by 8% to 2,244,713 units (withholding tax)Form 4Shares withheld for taxes or exercise price
- Jan 1, 2022DFTXSEC Form 3: New insider Barrow Robert claimed ownership of 2,435,000 units of Subordinate Voting SharesForm 3New insider
Compare Robert Barrow with
- Robert Barrow vs Daniel Karlin1 shared
- Robert Barrow vs Matthew T. Wiley1 shared
- Robert Barrow vs Mark Sullivan1 shared
- Robert Barrow vs Brandi Roberts1 shared
- Robert Barrow vs Carol A Vallone1 shared
- Robert Barrow vs Andreas Krebs1 shared
Other insiders at the same companies
- Daniel KarlinDFTX
- Matthew T. WileyDFTX
- Mark SullivanDFTX
- Brandi RobertsDFTX
- Carol A ValloneDFTX
- Andreas KrebsDFTX
- David W GryskaDFTX
- Roger CrystalDFTX
- Roger AdsettDFTX
- Suzanne Louise BruhnDFTX
- Carrie LiaoDFTX
Questions about Robert Barrow
- What is Robert Barrow's role at Definium Therapeutics, Inc.?
- Robert Barrow reports to the SEC as chief Executive Officer and director at Definium Therapeutics, Inc. (DFTX), according to the latest filing on September 30, 2026.
- How many shares does Robert Barrow own?
- After the latest filing that states it, Robert Barrow directly owned 2,213,090 shares of Definium Therapeutics, Inc. (DFTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Barrow bought or sold stock recently?
- The most recent open-market purchase was on August 20, 2024: bought 1,000 shares of Mind Medicine (MindMed) Inc. (DFTX) for $6,215 at an average of $6.22. The most recent open-market sale was on September 25, 2026: sold 31,550 shares of Definium Therapeutics, Inc. (DFTX) for $1.15M at an average of $36.57.
- How do I get alerts when Robert Barrow files?
- Follow Robert Barrow on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Barrow filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert Barrow (SEC CIK 0001897557). Totals count each trade once, skipping amendments whose original is on file, from Jan 11, 2022 on. View on SEC EDGAR